Melanoma is the most dangerous form of skin cancer, but how serious it is depends almost entirely on when it’s caught. Melanoma found before it spreads beyond the skin has a five-year survival rate above 99%. Once it reaches distant organs, that number drops to about 35%. The gap between those two figures tells the whole story: early-stage melanoma is highly curable, while late-stage melanoma is life-threatening.
Stage at Diagnosis Changes Everything
Melanoma’s seriousness is measured primarily by how deep it has grown into the skin and whether it has spread. Doctors assess this using a measurement called Breslow thickness, which is the depth of the tumor in millimeters. A melanoma less than 1 mm deep with no ulceration (broken skin over the tumor) is classified as the earliest stage and carries an excellent prognosis. Thicker tumors, especially those deeper than 4 mm or showing ulceration, are far more dangerous even before they visibly spread.
The survival statistics break down into three broad categories based on how far the cancer has traveled:
- Localized (still in the skin): over 99% five-year survival
- Regional (spread to nearby lymph nodes): 76% five-year survival
- Distant (spread to organs like the lungs, liver, or brain): 34–35% five-year survival
These numbers come from the National Cancer Institute’s SEER database, covering patients diagnosed between 2015 and 2022. They reflect a wide range of outcomes within each category. A person with a single affected lymph node has a very different outlook than someone with cancer in multiple nodes.
Why Melanoma Is More Dangerous Than Other Skin Cancers
Most skin cancers, like basal cell and squamous cell carcinoma, grow slowly and rarely spread to other parts of the body. Melanoma is fundamentally different. It develops in the pigment-producing cells of the skin, and those cells have a natural ability to migrate, which melanoma exploits. The cancer can invade blood vessels and lymphatic channels, seeding itself in lymph nodes first and then colonizing distant organs. The lungs, liver, brain, and bones are common targets.
This capacity to metastasize is what makes melanoma responsible for the vast majority of skin cancer deaths, despite being far less common than other types.
How Fast Melanoma Can Progress
Not all melanomas grow at the same speed. The most common subtype, superficial spreading melanoma, tends to grow outward across the skin’s surface before pushing deeper. Its median growth rate is about 0.12 mm per month. Nodular melanoma, a more aggressive subtype, grows downward into the skin roughly four times faster, at about 0.49 mm per month. About one-third of all melanomas grow at 0.5 mm or more per month.
These numbers matter because depth drives danger. A melanoma that starts at under 1 mm could cross into higher-risk territory within just a few months if it’s a fast-growing type. This is why dermatologists push for prompt evaluation of changing moles. A delay of even a few months can shift a melanoma from a highly curable stage to one that requires aggressive treatment.
Recurrence After Treatment
Even after a melanoma is surgically removed, it can come back. Overall recurrence rates range from about 20% to 40%, depending on the original stage and thickness. The majority of recurrences happen early: roughly 67% within two years of diagnosis, and 80% within three years for early-stage cases.
Thicker melanomas and those diagnosed at more advanced stages tend to recur sooner. Stage IIC melanoma, for instance, where the tumor is over 4 mm thick with ulceration, behaves similarly to stage III disease in terms of recurrence risk. However, melanoma can also return late. About 18% of recurrences happen after the five-year mark, and some appear more than 10 years after the original diagnosis. This is why long-term follow-up with skin checks and imaging remains important for years after treatment.
Rarer Forms Are Often More Aggressive
When most people think of melanoma, they picture a dark spot on sun-exposed skin. But melanoma can also develop inside the body. Mucosal melanoma forms on the lining of the mouth, nasal passages, or genital tract, and uveal melanoma develops in the eye. These forms are uncommon, but they tend to be diagnosed later and carry a worse prognosis once they spread.
Once any melanoma type reaches the metastatic stage, survival timelines converge somewhat, but mucosal melanoma fares worst. Median survival from the time of first metastasis is about 9 months for mucosal melanoma, compared to roughly 11 to 13 months for the other subtypes. Acral melanoma, which occurs on the palms, soles, or under fingernails, also deserves attention because it’s the most common type in people with darker skin tones and is often diagnosed late simply because people aren’t looking for skin cancer in those locations.
Modern Treatment Has Changed the Outlook
The prognosis for advanced melanoma has improved dramatically in the past decade thanks to immunotherapy. Before these treatments existed, metastatic melanoma had a median survival of roughly one year. The picture now is strikingly different.
A landmark trial with 10 years of follow-up data found that patients with advanced melanoma who received a combination of two immunotherapy drugs had a median overall survival of nearly 72 months, or about six years. More than 37% of patients in that group were still alive at the 10-year mark. Even with a single immunotherapy agent, median survival reached about 37 months. These results represent one of the most significant improvements in cancer treatment outcomes in modern oncology.
That said, immunotherapy doesn’t work for everyone. Some melanomas don’t respond, and the treatments can cause serious side effects by overstimulating the immune system. The overall five-year survival rate for distant melanoma (34–35%) still reflects a mix of patients, some who responded well and others who didn’t.
What Determines Your Personal Risk
If you’ve been diagnosed with melanoma or are worried about a suspicious spot, the factors that matter most for seriousness are:
- Thickness: Thinner melanomas (under 1 mm) are almost always curable with surgery alone. Each millimeter of added depth significantly increases risk.
- Ulceration: If the skin over the melanoma is broken or eroded, the prognosis is worse at every thickness level. A thin melanoma with ulceration is staged higher than the same thickness without it.
- Lymph node involvement: Whether cancer cells have reached nearby lymph nodes is the clearest dividing line between early and more advanced disease.
- Location and type: Melanomas on the trunk or head tend to have worse outcomes than those on the arms or legs. Mucosal and acral subtypes are often caught later.
The single most important thing about melanoma’s seriousness is that catching it early essentially eliminates the danger. A thin melanoma removed with a simple surgical procedure has a cure rate approaching 100%. The same disease caught months or years later, after it has had time to grow deeper and spread, becomes a far more complex and dangerous problem. That enormous gap between early and late detection is what defines melanoma as a cancer where paying attention to your skin genuinely saves lives.